• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HS-SPME-GC-MS 作为雷尼替丁产品中 NDMA 分析的替代方法。

HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products.

机构信息

Drug Reference Laboratory, Saudi Food & Drug Authority (SFDA), 12843-7116, Riyadh, Saudi Arabia.

Drug Reference Laboratory, Saudi Food & Drug Authority (SFDA), 12843-7116, Riyadh, Saudi Arabia.

出版信息

J Pharm Biomed Anal. 2020 Nov 30;191:113582. doi: 10.1016/j.jpba.2020.113582. Epub 2020 Aug 21.

DOI:10.1016/j.jpba.2020.113582
PMID:32889348
Abstract

N-nitrosodimethylamine (NDMA) is a carcinogenic contaminant that was accidentally discovered in drugs, such as valsartan and ranitidine, and more recently in metformin. Liquid chromatography tandem mass spectrometry (LC-MS/MS) is the method typically used for the analysis of NDMA in ranitidine. It seems that using gas chromatography (GC) for NDMA analysis is problematic as ranitidine is sensitive to high temperatures. In the present study, we assessed the usefulness of solid-phase microextraction (SPME) as a method of extraction and introduction into the GC. When using headspace (HS) and liquid injection modes in GC for NDMA analysis in ranitidine, higher NDMA levels were detected compared to using LC-MS/MS. Interestingly, using HS-SPME-GC-MS was advantageous because we could avoid the high temperature utilized in the liquid injection and HS modes. Moreover, the results obtained using HS-SPME-GC-MS provided a good match with those achieved using LC-MS/MS. The feasibility of using HS-SPME-GC-MS to successfully analyze NDMA in ranitidine opens new opportunities for the analysis of this contaminant in pharmaceuticals, specifically those that are heat-labile.

摘要

N-亚硝基二甲胺(NDMA)是一种致癌污染物,它意外地在药物中被发现,如缬沙坦和雷尼替丁,最近又在二甲双胍中被发现。液相色谱串联质谱法(LC-MS/MS)通常用于分析雷尼替丁中的 NDMA。似乎使用气相色谱法(GC)分析 NDMA 存在问题,因为雷尼替丁对高温敏感。在本研究中,我们评估了固相微萃取(SPME)作为一种提取和引入 GC 的方法的有用性。当在 GC 中使用顶空(HS)和液体进样模式分析雷尼替丁中的 NDMA 时,与使用 LC-MS/MS 相比,检测到的 NDMA 水平更高。有趣的是,使用 HS-SPME-GC-MS 具有优势,因为我们可以避免液体进样和 HS 模式中使用的高温。此外,使用 HS-SPME-GC-MS 获得的结果与使用 LC-MS/MS 获得的结果非常吻合。HS-SPME-GC-MS 成功分析雷尼替丁中 NDMA 的可行性为分析热不稳定药物中的这种污染物开辟了新的机会。

相似文献

1
HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products.HS-SPME-GC-MS 作为雷尼替丁产品中 NDMA 分析的替代方法。
J Pharm Biomed Anal. 2020 Nov 30;191:113582. doi: 10.1016/j.jpba.2020.113582. Epub 2020 Aug 21.
2
Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals.评估和优化 HS-SPME 辅助 GC-MS/MS 方法用于监测多种药物中的亚硝胺杂质。
J Pharm Biomed Anal. 2022 Nov 30;221:115003. doi: 10.1016/j.jpba.2022.115003. Epub 2022 Aug 22.
3
Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry.沉淀和固相萃取-气相色谱-串联质谱法测定沙坦类、二甲双胍和雷尼替丁药物中的 N-亚硝基二甲胺和 N-亚硝基甲基乙胺。
J Pharm Biomed Anal. 2020 Sep 10;189:113460. doi: 10.1016/j.jpba.2020.113460. Epub 2020 Jul 4.
4
Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography-tandem mass spectrometry.采用固相萃取-液相色谱-串联质谱法从药物中分离 N-亚硝基二甲胺。
J Pharm Biomed Anal. 2022 Feb 20;210:114561. doi: 10.1016/j.jpba.2021.114561. Epub 2021 Dec 29.
5
A solvent-free headspace GC/MS method for sensitive screening of N-nitrosodimethylamine in drug products.一种无溶剂顶空 GC/MS 法,用于药物产品中痕量 N-亚硝基二甲胺的灵敏筛查。
Anal Methods. 2021 Aug 14;13(30):3402-3409. doi: 10.1039/d1ay01036k. Epub 2021 Jul 12.
6
NDMA analytics in metformin products: Comparison of methods and pitfalls.二甲双胍产品中 NDMA 的分析:方法比较与陷阱。
Eur J Pharm Sci. 2022 Jan 1;168:106026. doi: 10.1016/j.ejps.2021.106026. Epub 2021 Sep 29.
7
Optimization of Headspace Solid-Phase Microextraction (HS-SPME) Parameters for the Analysis of Pyrazines in Yeast Extract via Gas Chromatography Mass Spectrometry (GC-MS).通过气相色谱-质谱联用(GC-MS)分析酵母抽提物中吡嗪的顶空固相微萃取(HS-SPME)参数优化。
J Food Sci. 2019 Aug;84(8):2031-2041. doi: 10.1111/1750-3841.14694. Epub 2019 Jul 5.
8
NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines.缬沙坦和其他药物产品中的 NDMA 杂质:N-亚硝胺的测定分析方法。
J Pharm Biomed Anal. 2019 Feb 5;164:536-549. doi: 10.1016/j.jpba.2018.11.010. Epub 2018 Nov 12.
9
Development of a new methodology for the determination of N-nitrosamines impurities in ranitidine pharmaceuticals using microextraction and gas chromatography-mass spectrometry.一种使用微萃取和气相色谱-质谱联用技术测定雷尼替丁药物中N-亚硝胺杂质的新方法的开发。
Talanta. 2021 Feb 1;223(Pt 2):121659. doi: 10.1016/j.talanta.2020.121659. Epub 2020 Sep 15.
10
Temperature-Dependent Formation of N-Nitrosodimethylamine during the Storage of Ranitidine Reagent Powders and Tablets.温度对雷尼替丁试剂粉末和片剂贮藏过程中生成 N-亚硝基二甲胺的影响。
Chem Pharm Bull (Tokyo). 2020 Oct 1;68(10):1008-1012. doi: 10.1248/cpb.c20-00431. Epub 2020 Aug 8.

引用本文的文献

1
A New Analytical LC-MS/MS Method for Determination of Eight Standard Nitrosamines (NDMA, NMBA, NDEA, NEIPA, NDIPA, NMPA, NDPA, NDBA) in a Commercial Small Molecule Drug Product Capsules and its Active Pharmaeceutical Ingredient for Treatment of Fabry: A Rare Disease.一种用于测定商业小分子药品胶囊及其活性药物成分中八种标准亚硝胺(N-亚硝基二甲胺、N-亚硝基甲基苄胺、N-亚硝基二乙胺、N-亚硝基-N-乙基异丙胺、N-亚硝基-N-二异丙胺、N-亚硝基-N-甲基苯乙胺、N-亚硝基-N,N-二丙胺、N-亚硝基-N,N-二丁胺)的新型分析液相色谱-串联质谱法,该药品用于治疗法布里病:一种罕见病。
Pharm Res. 2025 Jun 17. doi: 10.1007/s11095-025-03875-7.
2
Analysis and risk assessment of nitrosamines in sartans using GC-MS and Monte Carlo simulation.使用气相色谱-质谱联用仪(GC-MS)和蒙特卡洛模拟对沙坦类药物中亚硝胺进行分析和风险评估。
Sci Rep. 2025 Jun 6;15(1):20032. doi: 10.1038/s41598-025-97844-0.
3
Sensitive determination of volatile nitrosamines with ambient pressure ammonium-adduct ionization mass spectrometry.常压铵加成电离质谱法灵敏测定挥发性亚硝胺。
Anal Bioanal Chem. 2024 Dec;416(29):6839-6847. doi: 10.1007/s00216-024-05580-7. Epub 2024 Oct 14.
4
Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices.分析方法检测原料药、药品及其他基质中的 N-亚硝胺杂质
Chem Res Toxicol. 2024 Sep 16;37(9):1456-1483. doi: 10.1021/acs.chemrestox.4c00234. Epub 2024 Aug 19.
5
Nitrosamines crisis in pharmaceuticals - Insights on toxicological implications, root causes and risk assessment: A systematic review.药品中的亚硝胺危机——关于毒理学影响、根本原因和风险评估的见解:一项系统综述
J Pharm Anal. 2024 May;14(5):100919. doi: 10.1016/j.jpha.2023.12.009. Epub 2023 Dec 12.
6
Development of a Sensitive Screening Method for Simultaneous Determination of Nine Genotoxic Nitrosamines in Active Pharmaceutical Ingredients by GC-MS.建立一种 GC-MS 法同时测定原料药中 9 种遗传毒性亚硝胺类物质的灵敏筛选方法。
Int J Mol Sci. 2022 Oct 12;23(20):12125. doi: 10.3390/ijms232012125.
7
N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.雷尼替丁产品中 N-亚硝基二甲胺(NDMA)的污染:近期发现的综述。
J Food Drug Anal. 2021 Mar 15;29(1):39-45. doi: 10.38212/2224-6614.1133.